Perpetual LTD Pfizer Inc Transaction History

Perpetual LTD

$10.2 Trillion
Q1 2024

A detailed history of Perpetual LTD transactions in Pfizer Inc stock. As of the latest transaction made, Perpetual LTD holds 68,337 shares of PFE stock, worth $1.96 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

68,337

Previous 68,337 -0.0%

Holding current value

$1.96 Million

Previous $1.9 Billion -0.0%

% of portfolio

0.02%

Previous 0.02%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 09, 2024	SELL	$25.89 - $29.73 $3,055 - $3,508	-118 Reduced 0.17%	68,337 $1.9 Billion
Q4 2023 Feb 15, 2024	SELL	$26.13 - $33.94 $1.09 Million - $1.42 Million	-41,777 Reduced 37.9%	68,455 $1.97 Billion
Q3 2023 Oct 10, 2023	BUY	$32.09 - $37.51 $1.67 Million - $1.95 Million	52,074 Added 89.54%	110,232 $3.66 Billion
Q2 2023 Jul 13, 2023	SELL	$36.12 - $41.79 $3.19 Million - $3.69 Million	-88,179 Reduced 60.26%	58,158 $2.13 Billion
Q1 2023 May 08, 2023	BUY	$39.39 - $51.28 $3.19 Million - $4.15 Million	80,914 Added 123.68%	146,337 $5.97 Billion

Q2 2020 Nov 18, 2020	BUY	$30.12 - $36.54 $1.97 Million - $2.39 Million	65,423 New	65,423 $4.51 Million
Q1 2020 Nov 18, 2020	SELL	$27.03 - $38.62 $1.77 Million - $2.53 Million	-65,423 Closed	0 $0
Q3 2019 Oct 10, 2019	BUY	$32.49 - $42.13 $113,715 - $147,455	3,500 Added 5.65%	65,423 $2.35 Million
Q2 2019 Jul 30, 2019	SELL	$36.98 - $41.52 $447,457 - $502,392	-12,100 Reduced 16.35%	61,923 $2.68 Million
Q3 2018 Oct 30, 2018	SELL	$34.47 - $41.81 $420,534 - $510,082	-12,200 Reduced 14.15%	74,023 $3.26 Million
Q2 2018 Jul 23, 2018	BUY	$32.98 - $35.16 $2.84 Million - $3.03 Million	86,223 New	86,223 $3.13 Million

Others Institutions Holding PFE

# of Institutions

3,154

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $161B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Perpetual LTD, based on Form 13F filings with the SEC.

News

Stay updated on Perpetual LTD with notifications on news.

Account